• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5050569)   Today's Articles (0)
For: Spring LM, Fell G, Arfe A, Sharma C, Greenup R, Reynolds KL, Smith BL, Alexander B, Moy B, Isakoff SJ, Parmigiani G, Trippa L, Bardia A. Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. Clin Cancer Res 2020;26:2838-2848. [PMID: 32046998 PMCID: PMC7299787 DOI: 10.1158/1078-0432.ccr-19-3492] [Citation(s) in RCA: 487] [Impact Index Per Article: 97.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2019] [Revised: 12/16/2019] [Accepted: 02/04/2020] [Indexed: 12/22/2022]
Number Cited by Other Article(s)
1
Xie L, Wang Y, Wan A, Huang L, Wang Q, Tang W, Qi X, Hu X. Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis. Hum Vaccin Immunother 2025;21:2460272. [PMID: 39904891 PMCID: PMC11801352 DOI: 10.1080/21645515.2025.2460272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2024] [Revised: 01/06/2025] [Accepted: 01/25/2025] [Indexed: 02/06/2025]  Open
2
Nierenberg TC, Thomas SM, Halliday I, Botty van den Bruele A, Chiba A, Modell Parrish KJ, Woriax HE, DiNome ML, Westbrook KE, Plichta JK. Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study. Breast Cancer Res Treat 2025;212:161-172. [PMID: 40349259 PMCID: PMC12118946 DOI: 10.1007/s10549-025-07717-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2025] [Accepted: 05/01/2025] [Indexed: 05/14/2025]
3
Ai D, Arrey EN, Postlewait LM, Gao Y, Li X. The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response. Histopathology 2025;86:1112-1120. [PMID: 39904575 DOI: 10.1111/his.15417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2024] [Revised: 12/30/2024] [Accepted: 01/15/2025] [Indexed: 02/06/2025]
4
Kim MJ, Kim HJ, Kim JY, Shin J, Park YH. Effectiveness of Adjuvant Capecitabine in Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Treatment: A Real-World Evidence Study in Korea. Clin Breast Cancer 2025;25:e431-e439.e4. [PMID: 39909791 DOI: 10.1016/j.clbc.2024.12.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2024] [Revised: 12/30/2024] [Accepted: 12/30/2024] [Indexed: 02/07/2025]
5
Liu H, Kou F, Hu L, Sun J, Zhang J, Xu Y, Yao L, Xie Y. Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy. Breast Cancer Res Treat 2025;211:705-715. [PMID: 40106205 DOI: 10.1007/s10549-025-07687-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Accepted: 03/14/2025] [Indexed: 03/22/2025]
6
Perry LM, Sevilimedu V, Polidorio N, Abuhadra N, Morrow M, Plitas G, Downs-Canner S. Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer. Ann Surg Oncol 2025;32:3991-4001. [PMID: 40025324 PMCID: PMC12055475 DOI: 10.1245/s10434-025-17081-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Accepted: 02/07/2025] [Indexed: 03/04/2025]
7
Huang Z, Liu Y, Li S, Li Y, Wu Z, He H, Yang Y, Jin L. IHC4 and COMBINE scores for enhanced prognostic stratification in HR+/HER2- breast cancer patients after neoadjuvant chemotherapy. Breast Cancer Res Treat 2025;211:307-319. [PMID: 39954110 PMCID: PMC12006200 DOI: 10.1007/s10549-025-07645-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2024] [Accepted: 02/10/2025] [Indexed: 02/17/2025]
8
Cabıoğlu N, Karanlık H, İğci A, Uras C, Dülgeroğlu O, Karadeniz Çakmak G, Sezer A, Gürleyik G, Tükenmez M, Bademler S, Müslümanoğlu M, Özkurt E, Yıldırım N, Uğurlu MÜ, Balbaloğlu H, Emiroğlu S, Özmen V, Güllüoğlu BM. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025;51:109642. [PMID: 40009910 DOI: 10.1016/j.ejso.2025.109642] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2024] [Revised: 01/11/2025] [Accepted: 01/24/2025] [Indexed: 02/28/2025]
9
Chen X, Ye H, Xu D, Chen S, Wu W, Qian X, Zhang X, Zou X, Chen J, Wang X. Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer. Front Immunol 2025;16:1570394. [PMID: 40421023 PMCID: PMC12104239 DOI: 10.3389/fimmu.2025.1570394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2025] [Accepted: 04/21/2025] [Indexed: 05/28/2025]  Open
10
Di Leone A, Franco A, Castagnetta V, Silenzi M, Accetta C, Carnassale B, D’Archi S, De Lauretis F, Di Guglielmo E, Gagliardi F, Magno S, Moschella F, Natale M, Sanchez AM, Scardina L, Masetti R, Franceschini G. Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer. Cancers (Basel) 2025;17:1619. [PMID: 40427118 PMCID: PMC12110214 DOI: 10.3390/cancers17101619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2025] [Revised: 04/29/2025] [Accepted: 05/07/2025] [Indexed: 05/29/2025]  Open
11
Wang X, Huang Y, Shi J, Cao Y, Chen H, Li L, Wang L, Tang S, Gong X, Huang H, Yin T, Zhang J. Biomechanical parameters quantified by MR elastography for predicting response to neoadjuvant chemotherapy and disease-free survival in breast cancer: a prospective longitudinal study. Breast Cancer Res 2025;27:72. [PMID: 40329402 PMCID: PMC12057177 DOI: 10.1186/s13058-025-02035-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2024] [Accepted: 04/24/2025] [Indexed: 05/08/2025]  Open
12
Kuemmel S, Graeser M, Schmid P, Reinisch M, Feuerhake F, Volk V, Armeanu-Ebinger S, Schütz L, Kelemen O, Schroeder C, Ossowski S, Jóźwiak K, Kostara A, Scheffen I, Lüdtke-Heckenkamp K, Hilpert F, Kentsch A, Ziske C, Depenbusch R, Braun M, Blohmer JU, Zu Eulenburg C, Christgen M, Bartels S, Kreipe HH, Wuerstlein R, Biehl C, Pelz E, Hartkopf A, Harbeck N, Gluz O. Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial. Lancet Oncol 2025;26:629-640. [PMID: 40318646 DOI: 10.1016/s1470-2045(25)00097-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2024] [Revised: 02/06/2025] [Accepted: 02/18/2025] [Indexed: 05/07/2025]
13
Mousa-Doust D, Bazzarelli A, Deban M, Dingee C, Newman-Bremang J, Pao JS, Warburton R, McKevitt E. Inflammatory breast cancer response to modern neoadjuvant chemotherapy: Tumor response and survival outcomes. Am J Surg 2025;243:116288. [PMID: 40088610 DOI: 10.1016/j.amjsurg.2025.116288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Revised: 01/22/2025] [Accepted: 03/03/2025] [Indexed: 03/17/2025]
14
Pesapane F, Rotili A, Scalco E, Pupo D, Carriero S, Corso F, De Marco P, Origgi D, Nicosia L, Ferrari F, Penco S, Pizzamiglio M, Rizzo G, Cassano E. Predictive value of tumoral and peritumoral radiomic features in neoadjuvant chemotherapy response for breast cancer: a retrospective study. LA RADIOLOGIA MEDICA 2025;130:598-612. [PMID: 39992329 DOI: 10.1007/s11547-025-01969-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2024] [Accepted: 02/05/2025] [Indexed: 02/25/2025]
15
Ferezini Oliveira de Sá G, Villarim PVDO, Saboia da Escossia Melo PH, Sarmento ACA, Gonçalves AK, Santos de Medeiros K, Rocha de Medeiros Miranda C. Evaluation of pathological complete response rates in breast cancer patients undergoing neoadjuvant therapy. REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRÍCIA 2025;47:e-rbgo13. [PMID: 40406477 PMCID: PMC12097449 DOI: 10.61622/rbgo/2025rbgo13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2024] [Accepted: 12/27/2024] [Indexed: 05/26/2025]  Open
16
Kivuyo N, Akoko L, Mutajwaha JOG, Haule C, Mosha I, Misidai M, Kitua D, Nyongole O, Mwanga A. Dismal pathological response to neoadjuvant chemotherapy in stage III breast cancer patients in Tanzania: A retrospective review. PLoS One 2025;20:e0321187. [PMID: 40267089 PMCID: PMC12017560 DOI: 10.1371/journal.pone.0321187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2024] [Accepted: 03/03/2025] [Indexed: 04/25/2025]  Open
17
Toney NJ, Lynch MT, Lynce F, Mainor C, Isaacs C, Schlom J, Donahue RN. Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy. J Immunother Cancer 2025;13:e011379. [PMID: 40274284 PMCID: PMC12020768 DOI: 10.1136/jitc-2024-011379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2024] [Accepted: 04/07/2025] [Indexed: 04/26/2025]  Open
18
Luo L, Wu M, Li M, Xin Y, Wang Q, Vardhanabhuti V, Chu WC, Li Z, Zhou J, Rajpurkar P, Chen H. A large model for non-invasive and personalized management of breast cancer from multiparametric MRI. Nat Commun 2025;16:3647. [PMID: 40246826 PMCID: PMC12006510 DOI: 10.1038/s41467-025-58798-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2024] [Accepted: 04/02/2025] [Indexed: 04/19/2025]  Open
19
Jin Y, Zhao M, Su T, Fan Y, Ouyang Z, Lv F. Comparing Random Survival Forests and Cox Regression for Nonresponders to Neoadjuvant Chemotherapy Among Patients With Breast Cancer: Multicenter Retrospective Cohort Study. J Med Internet Res 2025;27:e69864. [PMID: 40198909 PMCID: PMC12015342 DOI: 10.2196/69864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2024] [Revised: 02/19/2025] [Accepted: 03/25/2025] [Indexed: 04/10/2025]  Open
20
Wu C, Lima EABF, Stowers CE, Xu Z, Yam C, Son JB, Ma J, Rauch GM, Yankeelov TE. MRI-based digital twins to improve treatment response of breast cancer by optimizing neoadjuvant chemotherapy regimens. NPJ Digit Med 2025;8:195. [PMID: 40195521 PMCID: PMC11976917 DOI: 10.1038/s41746-025-01579-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Accepted: 03/20/2025] [Indexed: 04/09/2025]  Open
21
Kumar U, Mishra AK, Singh KR, Parihar A, Raja N, Raam M, Rahalkar A, Ramakant P. Does Mammography Density Change the Response to Neoadjuvant Chemotherapy and Predict a Pathological Complete Response Rate? World J Surg 2025;49:780-788. [PMID: 39988559 DOI: 10.1002/wjs.12502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Revised: 01/07/2025] [Accepted: 01/20/2025] [Indexed: 02/25/2025]
22
Wan CF, Jiang ZY, Wang YQ, Wang L, Fang H, Jin Y, Dong Q, Zhang XQ, Jiang LX. Radiomics of Multimodal Ultrasound for Early Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer. Acad Radiol 2025;32:1861-1873. [PMID: 39690072 DOI: 10.1016/j.acra.2024.11.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2024] [Revised: 11/03/2024] [Accepted: 11/04/2024] [Indexed: 12/19/2024]
23
Antonini M, Mattar A, Pereira da Costa Pinheiro DJ, Maia IB, Teixeira MD, Amorim AG, Ferraro O, Chrispim de Oliveira L, Ramos MDNM, Cavalcante FP, Zerwes F, Madeira M, Barroso-Sousa R, de Camargo Millen E, Frasson AL, Brenelli FP, Facina G, Fenile R, Gebrim LH, Real JM. Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems. Breast 2025;80:104417. [PMID: 39983435 PMCID: PMC11893340 DOI: 10.1016/j.breast.2025.104417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Revised: 01/08/2025] [Accepted: 02/06/2025] [Indexed: 02/23/2025]  Open
24
Shah M, Rath S, Gulia S, Bhargava P, Sekar A, Rane S, Bajpai J, Shet T, Desai S, Sarin R, Pathak R, Popat P, Parab P, Kembhavi Y, Jethwa D, Dutta S, Patil A, Nair N, Rane P, Shetake A, Kolkur M, Joshi S, Badwe RA, Gupta S. Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy. JCO Glob Oncol 2025;11:e2400365. [PMID: 40267382 DOI: 10.1200/go-24-00365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 02/01/2025] [Accepted: 03/13/2025] [Indexed: 04/25/2025]  Open
25
Huang Y, Wang X, Cao Y, Lan X, Hu X, Mou F, Chen H, Gong X, Li L, Tang S, Wang L, Zhang J. Nomogram for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using MRI-based Intratumoral Heterogeneity Quantification. Radiology 2025;315:e241805. [PMID: 40232145 DOI: 10.1148/radiol.241805] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/16/2025]
26
Ji D, Lan B, Wang J, Ma F, Luo Y, Li Q, Zhang P, Cai R, Li Q, Chen S, Xu B, Fan Y. Clinicopathological Factors That Predict Different Responses of Breast and Axillary Tumors to Neoadjuvant Chemotherapy and Prognosis Among Patients With Node-Positive Breast Cancer: Real World Data. Thorac Cancer 2025;16:e70035. [PMID: 40176396 PMCID: PMC11965701 DOI: 10.1111/1759-7714.70035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2024] [Revised: 02/14/2025] [Accepted: 02/25/2025] [Indexed: 04/04/2025]  Open
27
Naldi L, Peri A, Fibbi B. Apelin/APJ: Another Player in the Cancer Biology Network. Int J Mol Sci 2025;26:2986. [PMID: 40243599 PMCID: PMC11988549 DOI: 10.3390/ijms26072986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2024] [Revised: 03/17/2025] [Accepted: 03/20/2025] [Indexed: 04/18/2025]  Open
28
Zhang N, Shan M, Huang Z, Gao F, Xu B, Kang W, Zhang J, Song L, Liu J, Zhang J, Liu M, Jiang H, Liu X, Shen Z, Zhang P, Nanding A, Zhang G. Screening and exploration of neoadjuvant "de-escalation" therapy for early breast cancer. Front Pharmacol 2025;16:1574665. [PMID: 40201691 PMCID: PMC11975863 DOI: 10.3389/fphar.2025.1574665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2025] [Accepted: 03/10/2025] [Indexed: 04/10/2025]  Open
29
Kim H, Choi JS, Chi SA, Ryu JM, Lee JE, Kim MK, Lee J, Ko ES, Ko EY, Han BK. Digital mammography with AI-based computer-aided diagnosis to predict neoadjuvant chemotherapy response in HER2-positive and triple-negative breast cancer patients: comparison with MRI. Eur Radiol 2025:10.1007/s00330-025-11390-x. [PMID: 40131473 DOI: 10.1007/s00330-025-11390-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2024] [Revised: 11/28/2024] [Accepted: 01/01/2025] [Indexed: 03/27/2025]
30
Zheng C, Zheng D, Zhang Y, Lin R, Zheng Z. A population‑based propensity score matching analysis of neoadjuvant compared to adjuvant chemotherapy in luminal breast cancer. Sci Rep 2025;15:9568. [PMID: 40113956 PMCID: PMC11926370 DOI: 10.1038/s41598-025-93934-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2024] [Accepted: 03/10/2025] [Indexed: 03/22/2025]  Open
31
de Souza JS, Reitz LK, Copetti CLK, Moreno YMF, Vieira FGK, Di Pietro PF. Lower Adherence to Lifestyle Recommendations of the World Cancer Research Fund/American Institute for Cancer Research (2018) Is Associated with Decreased Overall 10-Year Survival in Women with Breast Cancer. Nutrients 2025;17:1001. [PMID: 40290024 PMCID: PMC11945812 DOI: 10.3390/nu17061001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2025] [Revised: 03/05/2025] [Accepted: 03/07/2025] [Indexed: 04/30/2025]  Open
32
Ni P, Li Y, Wang Y, Wei X, Liu W, Wu M, Zhang L, Zhang F. Construction of a nomogram prediction model for the pathological complete response after neoadjuvant chemotherapy in breast cancer: a study based on ultrasound and clinicopathological features. Front Oncol 2025;15:1459914. [PMID: 40115015 PMCID: PMC11922718 DOI: 10.3389/fonc.2025.1459914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2024] [Accepted: 02/18/2025] [Indexed: 03/22/2025]  Open
33
Akula V, Chen L, Acikgoz Y, Klein K, Yavuz BG, Cevik L, Demir T, Manne A, Sahin I, Kaseb A, Hasanov E. Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma. NPJ Precis Oncol 2025;9:60. [PMID: 40050446 PMCID: PMC11885445 DOI: 10.1038/s41698-025-00846-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2024] [Accepted: 02/24/2025] [Indexed: 03/09/2025]  Open
34
Yoshino T, Zhang Z, Sato R, Lipkowitz S, Fujii T. Revisiting surrogacy of pathological complete response for long-term survival in triple-negative breast cancer. JNCI Cancer Spectr 2025;9:pkaf022. [PMID: 39992221 PMCID: PMC11932712 DOI: 10.1093/jncics/pkaf022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 01/03/2025] [Accepted: 02/10/2025] [Indexed: 02/25/2025]  Open
35
Yuan Y, Liu X, Xu G, Zhang J, Chen L, Long X. Comparative efficacy and safety of pyrotinib plus trastuzumab versus trastuzumab plus pertuzumab and trastuzumab monotherapy in neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis. Cancer Treat Rev 2025;134:102901. [PMID: 39986012 DOI: 10.1016/j.ctrv.2025.102901] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2024] [Revised: 02/09/2025] [Accepted: 02/10/2025] [Indexed: 02/24/2025]
36
Huang Y, Shi Z, Zhu T, Zhou T, Li Y, Li W, Qiu H, Wang S, He L, Wu Z, Lin Y, Wang Q, Gu W, Gu C, Song X, Zhou Y, Guan D, Wang K. Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2025;12:e2413702. [PMID: 39921294 PMCID: PMC11948082 DOI: 10.1002/advs.202413702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/25/2024] [Revised: 12/30/2024] [Indexed: 02/10/2025]
37
Szwiec M, Tomiczek-Szwiec J, Marciniak W, Derkacz R, Huzarski T, Cybulski C, Gronwald J, Osowiecka K, Sibilski R, Narod SA, Lubiński J. The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy. Cancers (Basel) 2025;17:839. [PMID: 40075686 PMCID: PMC11898521 DOI: 10.3390/cancers17050839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Revised: 02/24/2025] [Accepted: 02/25/2025] [Indexed: 03/14/2025]  Open
38
Foidart P, Jerusalem G. Is adjuvant olaparib standard of care in all high-risk HER2-negative early breast cancer presenting gBRCA1/2 mutations? Gland Surg 2025;14:257-262. [PMID: 40115853 PMCID: PMC11921398 DOI: 10.21037/gs-24-467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2024] [Accepted: 02/03/2025] [Indexed: 03/23/2025]
39
Li W, Onishi N, Gibbs JE, Wilmes LJ, Le NN, Metanat P, Price ER, Joe BN, Kornak J, Yau C, Wolf DM, Magbanua MJM, LeStage B, van ’t Veer LJ, DeMichele AM, Esserman LJ, Hylton NM. MRI-Based Model for Personalizing Neoadjuvant Treatment in Breast Cancer. Tomography 2025;11:26. [PMID: 40137566 PMCID: PMC11946387 DOI: 10.3390/tomography11030026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2024] [Revised: 02/19/2025] [Accepted: 02/25/2025] [Indexed: 03/29/2025]  Open
40
Liang G, Zhang Q, Luo Y, Zhao Y, Luo B. Efficacy of anlotinib and chemotherapy combination as neoadjuvant therapy in the treatment of pulmonary artery intimal sarcoma: a case report. Front Oncol 2025;15:1507281. [PMID: 40078190 PMCID: PMC11897571 DOI: 10.3389/fonc.2025.1507281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2024] [Accepted: 02/07/2025] [Indexed: 03/14/2025]  Open
41
Richter FGB, Mattar A, Antonini M, Teixeira MD, Amorim AG, Millen EC, Brenelli FP, Cavalcante FP, Zerwes F, Frasson AL, Lopes RGC, Gebrim LH, Real JM. The relationship between body mass index and pathological complete response in Brazilian breast cancer patients. Sci Rep 2025;15:6174. [PMID: 39979484 PMCID: PMC11842549 DOI: 10.1038/s41598-025-89841-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2024] [Accepted: 02/07/2025] [Indexed: 02/22/2025]  Open
42
Wang J, Wang X, He Y, Wang T, Li J, Fan Z, Ouyang T. Comparison of 10-Year Survival Between Patients With Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy and Patients With Initially Negative Nodes in Breast Cancer. Clin Breast Cancer 2025:S1526-8209(25)00035-7. [PMID: 40038007 DOI: 10.1016/j.clbc.2025.02.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Accepted: 02/06/2025] [Indexed: 03/06/2025]
43
Shen G, Liu Z, Wang M, Zhao Y, Liu X, Hou Y, Ma W, Han J, Zhou X, Ren D, Zhao F, Li Z, Huang S, Chen Y, He Y, Liu Y, Zhu Z, Li Y, Li J, Da M, Mo H, Du F, Cui L, Bai J, Liu Z, Ma F, Zhao J. Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial. Signal Transduct Target Ther 2025;10:41. [PMID: 39915443 PMCID: PMC11802755 DOI: 10.1038/s41392-025-02137-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2024] [Revised: 01/03/2025] [Accepted: 01/10/2025] [Indexed: 02/09/2025]  Open
44
Connors C, Valente SA, ElSherif A, Escobar P, Chichura A, Kopicky L, Roesch E, Ritner J, McIntire P, Wu Y, Tu C, Lang JE. Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer. Ann Surg Oncol 2025;32:912-921. [PMID: 39436619 PMCID: PMC11843215 DOI: 10.1245/s10434-024-16390-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Accepted: 10/07/2024] [Indexed: 10/23/2024]
45
Ben Dhia S, Schiappa R, Gal J, Ferrero JM, Bahadoran P, Chapellier C, Bondiau PY. Cyberneo trial investigating the efficacy of stereotactic radiotherapy combined to neoadjuvant chemotherapy for locally advanced breast cancer: 14-years follow-up results. Cancer Radiother 2025;29:104592. [PMID: 40020436 DOI: 10.1016/j.canrad.2025.104592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2024] [Revised: 10/01/2024] [Accepted: 10/02/2024] [Indexed: 03/03/2025]
46
Chen R, Iwai T, Tajima H, Adachi K, Okuwaki K, Watanabe M, Hanaoka T, Tamaki A, Kumamoto Y, Kusano C. S-1/irinotecan/oxaliplatin chemotherapy achieved a pathological complete remission in advanced pancreatic carcinoma. Clin J Gastroenterol 2025;18:220-223. [PMID: 39503980 DOI: 10.1007/s12328-024-02055-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2024] [Accepted: 10/20/2024] [Indexed: 02/01/2025]
47
Di Rito A, Grillo A, Carbonara R. Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review. Curr Oncol Rep 2025;27:120-134. [PMID: 39826033 DOI: 10.1007/s11912-024-01629-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/17/2024] [Indexed: 01/20/2025]
48
Mattar A, Antonini M, Amorim AG, Teixeira MD, de Resende CAA, Cavalcante FP, Zerwes F, Arakelian R, Millen EDC, Brenelli FP, Frasson AL, Leite RM, Gebrim LH. Overall Survival and Economic Impact of Triple-Negative Breast Cancer in Brazilian Public Health Care: A Real-World Study. JCO Glob Oncol 2025;11:e2400340. [PMID: 39977709 DOI: 10.1200/go-24-00340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2024] [Revised: 12/11/2024] [Accepted: 01/09/2025] [Indexed: 02/22/2025]  Open
49
Rakha EA, Quinn C, Fox S, Masannat YA, Karakatsanis A, Dixon JM. Reply to the Editor: Reassessing margin standards in breast-conserving therapy. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2025;51:109504. [PMID: 39647446 DOI: 10.1016/j.ejso.2024.109504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2024] [Accepted: 11/28/2024] [Indexed: 12/10/2024]
50
Choi SE, Park AY, Kim GI, Jung HK, Ko KH, Kim Y. The kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density. Medicine (Baltimore) 2025;104:e40239. [PMID: 39889156 PMCID: PMC11789864 DOI: 10.1097/md.0000000000040239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Revised: 10/05/2024] [Accepted: 10/07/2024] [Indexed: 02/02/2025]  Open
PrevPage 1 of 10 12345910Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Excel